الفهرس | Only 14 pages are availabe for public view |
Abstract Evidence points to the so-called ”cytokine storm,” which can be defined as an uncontrolled overproduction of soluble mediators of inflammation that leads to an abnormal systemic inflammatory response, is a crucial factor in the development of severe forms of the disease and ARDS. There are few treatment options for severe COVID-19. A therapeutic strategy that relies on immunomodulatory medication to reduce the cytokine storm could provide insight into COVID-19 treatment. The use of an immunomodulatory drug to attenuate the cytokine storm may allow additional time for patients with COVID-19 to receive supportive care. Using a variety of therapeutic options, several procedures proposed different techniques to control the cytokine release storm. |